Abstract. The primary mediator of NaCl reabsorption in the renal distal tubule is the human bumetanide-sensitive Na ϩ -K ϩ -2Cl Ϫ co-transporter (hNKCC2), located at the apical membrane of the thick ascending limb of Henle's loop. The physiologic importance of this transporter is emphasized by the tubular disorder Bartter syndrome type I, which arises from the functional impairment of hNKCC2 as a result of mutations in the SLC12A1 gene. The aim of the present study was to investigate the oligomeric state of hNKCC2 to understand further its operational mechanism. To this end, hNKCC2 was heterologously expressed in Xenopus laevis oocytes. Chemical cross-linking with dimethyl-3,3-dithio-bis-propionamidate indicated that hNKCC2 subunits can reversibly form high molecular weight complexes. Co-immunoprecipitation of tagged hNKCC2 subunits further substantiated a physical interaction between individual hNKCC2 subunits. The size of the hNKCC2 multimers was determined by sucrose gradient centrifugation, and a preference for dimeric complexes (approximately 320 kD) was demonstrated. Finally, concatemeric constructs consisting of two wild-type subunits or a wild-type and a functionally impaired hNKCC2 subunit (G319R) were expressed in oocytes. Subsequently, the concatemers were functionally characterized, resulting in a significant bumetanidesensitive 22 Na ϩ uptake of 2.5 Ϯ 0.2 nmol/oocyte per 30 min for the wild-type-wild-type concatemer, which was reduced to 1.3 Ϯ 0
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The primary mediator of NaCl reabsorption in the renal distal tubule is the bumetanide-sensitive Na ϩ -K ϩ -2Cl Ϫ co-transporter (hNKCC2), located at the apical membrane of the thick ascending limb of Henle's loop (TAL) (1) . This co-transporter is responsible for Ͼ25% of the active sodium reabsorption in the kidney. It is, therefore, an important factor in the regulation of the circulating fluid volume and in long-term BP control. Through the innate sensitivity for loop diuretics, NKCC2 has been pinpointed as a prime target in the treatment of hypertension. The physiologic importance of TAL is further illustrated by the fact that this nephron segment plays a significant role in the urinary concentrating mechanism as a result of the uncoupling of water and NaCl reabsorption (2) . In addition, malfunctioning of this nephron segment can have severe clinical consequences. Impairment of the key transport proteins in TAL, including NKCC2, the ATP-sensitive K ϩ channel (ROMK), the Cl Ϫ channel (ClC-Kb), and its associated subunit
Barttin, results in the severe tubular transport disorder Bartter syndrome (3-7). NKCC2 (SLC12A1) is a member of the SLC12A superfamily of electroneutral cation-coupled co-transporters encompassing two Na ϩ -K ϩ -2Cl Ϫ co-transporters (NKCC1 and NKCC2) (8,9), the Na ϩ -Cl Ϫ co-transporter (NCC) (10,11), and at least four K ϩ -Cl Ϫ co-transporters (KCC1 to 4) (12-16). Genes encoding these transmembrane proteins are highly homologous and share a common predicted membrane topology of 12 transmembrane domains with both N-and C-terminus located intracellularly (17,18). In addition, the SLC12A1 gene encodes six different isoforms of NKCC2. These splice variants are created by a combination of three separate exon 4 cassettes (a, b, and f) and two alternative C-termini. This results in three long (1099 aa) and three short or truncated isoforms (770 aa) (19, 20) . These different isoforms display axial expression along the TAL and show significant differences in kinetic behavior, consistent with their spatial distribution as they reabsorb Na ϩ , K ϩ , and Cl Ϫ from progressively diluted luminal fluid (21,22). The short isoforms, when expressed separately, are able to exhibit only a K ϩ -independent mode of NaCl transport under hypotonic conditions (23). However, when coexpressed with their longer relatives in Xenopus laevis oocytes, they exert a negative effect on the latter, which in turn can be abolished by cAMP (24). These studies suggest that an interaction between individual NKCC2 subunits can occur. It has been shown that other family members, including the basolateral Na ϩ -K ϩ -2Cl Ϫ co-transporter NKCC1 (SLC12A2) and the K (3, 27) .
The aim of the present study was to assess the oligomeric state of hNKCC2 to understand further its operational mechanism. To this end, HA-and FLAG-tagged NKCC2 constructs were generated and heterologously expressed in Xenopus laevis oocytes. Subsequently, four independent techniques, including chemical cross-linking, co-immunoprecipitation, density gradient centrifugation, and the analysis of concatemeric proteins, were used to determine the quaternary structure of this Na
Materials and Methods

Synthesis of Tagged hNKCC2a Constructs
NKCC2a cDNA was obtained from a human kidney cDNA library (Clontech Laboratories, Palo Alto, CA) by means of PCR and cloned into a pGEM-T easy vector (Promega, Madison, WI). The coding sequence was subcloned into a custom oocyte expression vector, pTLN (28). A FLAG-epitope ("DYKDDDDK"; IBI, Kodak, New Haven, CT) or an influenza hemagglutinin (HA) epitope ("YPYDVP-DYA") (29), was cloned at the 5' end of the wild-type construct replacing the original ATG to allow distinction between subunits during the immunoprecipitation experiments. All constructs were checked by double-stranded sequence analysis. No cross-reactivity of HA-tagged hNKCC2a with FLAG-antibody or FLAG-tagged hNKCC2a with HA-antibody was observed during the immunoblotting experiments.
Preparation and Injection of Oocytes
Oocytes were obtained from Xenopus laevis and defolliculated by incubation for 2 h in modified Barth's solution (MBS; 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 10 mM HEPES-Tris [N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid] pH 7.4, 0.8 mM MgSO 4 , 0.3 mM Ca[NO 3 ] 2 , 0.4 mM CaCl 2 , and 25 g/ml gentamycin) containing 2 mg/ml collagenase A (Roche Molecular Biochemicals, Mannheim, Germany). Stage V and VI oocytes were selected and stored at 18°C in MBS. G-capped RNA transcripts were synthesized in vitro from Mlu I-linearized human NKCC2 templates using SP6 RNA polymerase. cRNA integrity was checked by agarose gel electrophoresis, and their concentrations were determined using spectrophotometric analysis. Defolliculated oocytes were injected with 50 nl of water containing 0 to 25 ng of cRNA and incubated 72 h at 18°C in MBS.
Isolation of Total Membranes
For isolation of total membranes (plasma and subcellular membranes), 10 to 50 oocytes were homogenized in 1 ml of homogenization buffer (20 mM Tris-HCl [pH 7.4], 5 mM MgCl 2 , 5 mM NaH 2 PO 4 , 1 mM EDTA, 80 mM sucrose, 1 mM PMSF, 5 g/ml leupeptin, and 5 g/ml pepstatin) and centrifuged two times for 10 min at 100 ϫ g and 4°C to remove yolk proteins. Next, the total membranes were pelleted by centrifugation at 16,200 ϫ g at 4°C for 30 min and subsequently dissolved in Laemmli-buffer (2 l/oocyte) and incubated 30 to 60 min at 37°C as described previously (30).
Immunoblot Analysis
Aliquots of dissolved total membranes were subjected to SDS-PAGE electrophoresis (7% wt/vol) and electroblotted onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). Blots were incubated with 5% (wt/vol) nonfat dried milk (NFDM) in Trisbuffered saline (TBS-T; pH 7.4 containing 0.2% [wt/vol] tween-20). Immunoblots were incubated overnight at 4°C with primary antibodies including mouse anti-FLAG-peroxidase coupled antibodies (Sigma Chemical Co., St. Louis, MO), 1:2000, 5% (wt/vol) NFDM in TBS-T, mouse anti-HA (Roche, Indianapolis, IN), 1:4000, 1% (wt/ vol) NFDM in TBS-T or mouse anti-HA-peroxidase (Roche), 1:1000, 1% (wt/vol) NFDM in TBS-T. After washing, HA blots were incubated at room temperature with the corresponding secondary antibody sheep anti-mouse IgG peroxidase (Sigma), 1:2000, in TBS-T, and immunopositive bands were visualized using an enhanced chemiluminescence system (Pierce, Rockford, IL).
Cross-Linking of Proteins
Total membrane preparations of oocytes expressing FLAGhNKCC2 were resuspended and incubated for 30 min at 37°C in cross-linking buffer (0.5% [wt/vol] sodium desoxycholate, 20 mM HEPES-NaOH [pH 7.2], 5 mM KCl, 130 mM NaCl, 10% [vol/vol] glycerol, 5 mM EDTA, and protease inhibitors). Samples were divided into three equal amounts. Two parts were treated with 2 mM dimethyl-3,3'-dithio-bispropionamidate (DTBP), a cleavable crosslinker with an 11.9 Å arm, in cross-linking buffer and incubated for 60 min on ice. Subsequently, cross-linking was terminated by the addition of 100 mM Tris-HCl (pH 6.8), and samples were incubated for 30 min on ice. Samples were incubated in Laemmli buffer for 30 min at 37°C with and without 100 mM dithiothreitol (DTT). As a control, the third part was not treated with DTBP.
Co-immunoprecipitation of FLAG-NKCC2 with HA-NKCC2
Twenty-microliter equivalents of protein A-coupled agarose beads (Pharmacia, Uppsala, Sweden) were preincubated for 16 h at 4°C with 2 l of monoclonal HA antibody (Roche) in 0.7 ml of IPP500 (500 mM NaCl, 10 mM sodium-desoxycholate, 1 mM PMSF, and 5 mg/ml leupeptin and pepstatin) and centrifuged at 16,000 ϫ g for 1 h at 4°C to pellet undissolved membranes. The solubilized membranes were diluted with 700 l of sucrose buffer (100 mM NaCl, 20 mM Tris-HCl [pH 6.8], 0.5 mM EDTA, 0.1% [vol/vol] Triton X100, 10% [wt/vol] sucrose, 1 mM PMSF, and 5 g/ml leupeptin and pepstatin), added to the washed antibody-bound protein A beads and incubated for 16 h at 4°C. After incubation, the beads were washed three times with IPP100, incubated in 25 l of Laemmli buffer for 1 h at 37°C, and subjected to immunoblotting (30). ] Triton X-100, 1 mM PMSF, and 5 mg/ml leupeptin and pepstatin) and centrifuged at 16,000 ϫ g for 1 h at 4°C to pellet undissolved membranes. The solubilized membranes were diluted with 700 l of sucrose buffer (100 mM NaCl, 20 mM Tris-HCl [pH 6.8], 0.5 mM EDTA, 0.1% [vol/vol] Triton X100, 10% (wt/vol) sucrose, 1 mM PMSF, and 5 g/ml leupeptin and pepstatin), added to the antibody-bound beads, and incubated for 16 h at 4°C. After incubation, the beads were washed three times with IPP100, incubated in 25 l of Laemmli buffer for 1 h at 37°C, and subjected to immunoblotting.
Co-immunoprecipitation of HA-NKCC2 with FLAG-NKCC2
Sedimentation by Sucrose Gradient Centrifugation
Total membranes of 100 oocytes injected with 25 ng of FLAGhNKCC2 cRNA were incubated in solubilization buffer (1% [wt/vol] sodium-desoxycholate, 20 mM Tris-HCl [pH 6.8], 5 mM EDTA, 10% [wt/vol) glycerol, 1 mM PMSF, and 5 mg/ml leupeptin and pepstatin) for 1 h at 37°C and subsequently centrifuged for 1 h at 100,000 ϫ g and 4°C to pellet undissolved membranes (31). Samples were supplemented with gradient buffer (20 mM Tris-HCl [pH 6.8], 5 mM EDTA, 0.1% [vol/vol] Triton X-100, 1 mM PMSF, and 5 mg/ml leupeptin and pepstatin) to 300 l. Sedimentation by gradient centrifugation was done essentially as described by Jung et al. (32). Solutions of 10, 15, 20, 25, 30, and 35% (wt/vol) sucrose in gradient buffer were prepared. The dissolved membrane samples were loaded onto the gradient and subjected to 150,000 ϫ g centrifugation for 16 h at 8°C. Then 200-l fractions, designated 1 to 16, were collected carefully and analyzed by immunoblotting. As sedimentation markers, a mixture of phosphorylase B (97 kD), yeast alcohol dehydrogenase (150 kD), ␤-amylase (200 kD), catalase (232 kD), and apoferritin (443 kD) was used. All markers were obtained from Sigma.
Expression of Concatemeric hNKCC2 cDNA Constructs
Concatemeric constructs were produced by linking the coding sequences of two FLAG-hNKCC2a subunits in a head-to-tail manner. By replacing the stop codon of one FLAG-hNKCC2a with a linker of six glycines followed by a unique EcoRV restriction site, the in-frame insertion of a second FLAG-hNKCC2a subunit was enabled. Two FLAG-hNKCC2a dimers were constructed, a wild-type-wild-type and a wild-type-mutant configuration. For the wild-type-mutant configuration, the G319R mutant was selected. This mutant is functionally impaired but properly routed to the plasma membrane as described previously (33). The dimeric constructs were verified by restriction digestion and were heterologously expressed in oocytes as mentioned above. 
Results
Cross-Linking of hNKCC2 Subunits
Chemical cross-linking of hNKCC2, heterologously expressed in oocytes, showed that hNKCC2 monomers disappeared upon treatment with DTBP, whereas oligomeric complexes with a molecular mass of 300 to 400 kD appeared (Figure 1 ). DTBP contains a cleavable spacer, allowing the Figure 1 . Cross-linking of human bumetanide-sensitive Na ϩ -K ϩ -2Cl Ϫ co-transporter (hNKCC2) heterologously expressed in oocytes. Total membranes of 45 noninjected (A to C) and 25 ng of FLAGhNKCC2 injected oocytes (D to F) were isolated as described in Materials and Methods. One aliquot of each group was treated with the chemical cross-linker dimethyl-3,3'-dithio-bispropionamidate (DTBP; B and E), treated with DTBP and DTT (C and F), or used as untreated control (A and D). Samples were subjected to immunoblotting and stained with the mouse M2 anti-FLAG antibody (n ϭ 3 independent experiments). conjugate to be broken by DTT. Indeed, incubation of the cross-linked hNKCC2 complexes with DTT revealed recurrence of the monomers. Under similar conditions, no signal was detected for total membranes of noninjected oocytes.
Co-immunoprecipitation of HA-NKCC2 with FLAG-NKCC2
The results from the cross-link experiments indicated that hNKCC2 might be able to form multimeric complexes. To substantiate further these results, we investigated whether hNKCC2 subunits carrying HA or FLAG epitope tags could be co-immunoprecipitated when co-injected into oocytes. First, total membranes were isolated from oocytes expressing HAhNKCC2, FLAG-hNKCC2, or both to demonstrate protein expression and specificity of the applied antibodies. Immunoblotting confirmed expression of both proteins, which were specifically detected by the HA and FLAG antibodies, respectively ( Figure 2A ). Subsequently, HA-hNKCC2 and FLAGhNKCC2 proteins were coexpressed and immunoprecipitated with HA antibodies. Immunoblots containing the complexes were probed with a peroxidase coupled FLAG antibody. The results shown in Figure 2B demonstrate that FLAG-hNKCC2 can be co-immunoprecipitated with the HA antibody. Similar results were obtained when the immunoprecipitation was performed with FLAG antibodies and the corresponding immunoblot was probed with HA antibodies (Figure 2C ), thus confirming the formation of a multimeric hNKCC2 complex from both sites.
Determination of the hNKCC2 Complex Size
Because the aforementioned experiments suggest that hNKCC2 can form a multimeric complex, the size of these complexes was subsequently estimated. To this end, total membranes were isolated from oocytes expressing hNKCC2, solubilized in 1% (wt/vol) sodium-desoxycholate, and subjected to sucrose gradient centrifugation. Immunoblotting of 16 fractions collected from the gradient revealed that the peak intensity of hNKCC2 complexes was located in fraction 10 ( Figure 3A) . The sedimentation marker proteins, phosphorylase B (97), alcohol dehydrogenase (150), ␤-amylase (200 kD), catalase (232 KD), and apoferritin (443 kD) were loaded on a parallel sucrose gradient (peak marker fractions are indicated by arrows in Figure 3A) . A semilogarithmic plot of the peak marker fractions versus their molecular mass yielded the following formula to calculate the mass of the hNKCC2 complex: Figure 2 . Co-immunoprecipitation of FLAG-hNKCC2 and HA-NKCC2. cRNA of HA-hNKCC2 and/or FLAG-hNKCC2 was (co-)injected in oocytes. Subsequently, total membranes were isolated from injected oocytes and noninjected controls (Ni) and processed (n ϭ 3 independent experiments). (A) Immunoblot analysis demonstrating that both tagged co-transporters are expressed and that the applied antibodies do not cross-react. Five oocyte equivalents were loaded on the blot. (B) Co-immunoprecipitations were performed with the HA antibody, and subsequently immunoblots were stained with a peroxidase-coupled anti-FLAG antibody. Fifteen oocyte equivalents were used in the co-immunoprecipitation experiment and loaded on the immunoblot. (C) Co-immunoprecipitations were performed with the FLAG antibody, and subsequently immunoblots were stained with a peroxidase-coupled anti-HA antibody. Twentythree oocyte equivalents were used in the co-immunoprecipitation experiment and loaded on the immunoblot. (5 to 16) of a sucrose gradient containing total membranes of oocytes expressing hNKCC2 and subjected to ultracentrifugation. Increasing band intensities with an optimum in fraction 10 was observed, which corresponds to a complex of approximately 320 kD. Also shown is a control of total membranes expressing hNKCC2 (WT). Arrows indicate peak fractions of marker proteins (n ϭ 3). (B) Immunoblot loaded with sequentially collected fractions (5 to 16) of a sucrose gradient containing total membranes of oocytes expressing hNKCC2 in the presence of SDS and subjected to ultracentrifugation. A shift in peak intensity is seen from fraction 10 (in A) to fraction 5, corresponding to a molecular mass of approximately 150 kD (in B) as SDS dissolves the formed complexes. Also shown is a control of total membranes expressing hNKCC2 (WT; n ϭ 3).
M ϭ 47.38e 0.1974*fraction nr with R 2 ϭ 0.97, which indicated that hNKCC2 migrates as a complex with a molecular mass of approximately 340 kD, suggesting the formation of a dimeric complex. Sucrose gradient centrifugation in the presence of 0.1% (wt/vol) SDS reduced the molecular mass to approximately 160 kD, corresponding to the estimated size of the complex-glycosylated hNKCC2 monomer ( Figure 3B ).
Construction and Functional Analysis of Concatemeric hNKCC2 Dimers
To investigate the functionality of dimeric hNKCC2, we constructed a concatemeric protein. Expression of wild-type hNKCC2 and the dimeric concatemer was confirmed by immunoblot, demonstrating specific bands at approximately 160 kD for the monomer and approximately 320 kD for the dimer ( Figure 4A) . Subsequently, functional analysis was performed, and the bumetanide-sensitive 22 Na ϩ uptake was 2.6 Ϯ 0.2 and 2.5 Ϯ 0.2 nmol/oocyte per 30 min for the injected monomeric hNKCC2 and the wild-type-wild-type concatemer, respectively ( Figure 4B ).
To gain additional information on the function of dimeric hNKCC2, we constructed a dimeric concatemer in which one of the subunits carried a mutation previously identified in Bartter syndrome type I. The G319R mutation was selected because it is normally processed in oocytes but functionally impaired as shown previously (33). Protein expression of both concatemers was confirmed by immunoblot ( Figure 5A ), and the bumetanide-sensitive Na ϩ transport activity of oocytes expressing the wild-type-wild-type or the wild-type-G319R dimer was measured, resulting in an uptake of 2.5 Ϯ 0.2 and 1.3 Ϯ 0.1 nmol/oocyte per 30 min, respectively ( Figure 5B) . Thus, the Na ϩ uptake was significantly reduced (P Ͻ 0.05) in the wild-type-G319R concatemer. To verify subcellular localization of the WT-G319R concatemer, we performed immunocytochemistry on oocytes injected with 25 ng WT-G319R cRNA ( Figure 5C ) or noninjected controls ( Figure 5D ). The results clearly show a plasma membrane localization for the WT-G319R concatemer similar to the previously published results for WT or G319R alone (33).
Discussion
The present study suggests that the human bumetanidesensitive Na ϩ -K ϩ -2Cl Ϫ co-transporter is functionally present at the plasma membrane as a homodimeric complex. Four independent methods were combined to assess the multimeric state of the co-transporter complex. First, chemical crosslinking experiments revealed protein band shifts from monomeric hNKCC2 to multimeric compositions. Second, co-immunoprecipitation experiments demonstrated that hNKCC2 subunits are physically linked. Third, sucrose gradient centrifugation substantiated that hNKCC2 complexes have a molecular weight corresponding to a dimeric configuration. Fourth, tracer analysis of concatemeric proteins revealed that dimeric hNKCC2 complexes, when expressed in oocytes, exhibit a significant bumetanide-sensitive Na ϩ transport activity. The first indication that multimerization of hNKCC2 subunits occurs was obtained by cross-linking experiments. Addition of the chemical cross-linker DTBP resulted in a band shift of the hNKCC2 monomeric band to a larger configuration (Ͼ300 kD). This indicated that hNKCC2 subunits are present within 11.9 Å (the maximal bridging length of the cross-linker) of each other. Earlier, a study by Moore-Hoon et al. (25) suggested that the secretory Na ϩ -K ϩ -2Cl Ϫ co-transporter (NKCC1) forms a homodimeric complex. Recently, we applied a similar approach to show that the related thiazide-sensitive NaCl co-transporter (NCC) forms homodimers (37). Additional evidence of oligomerization was obtained by performing co-immunoprecipitation experiments using hNKCC2 subunits carrying different epitope tags. This proved that hNKCC2 subunits could physically interact when heterologously expressed in oocytes. In addition, sucrose gradient centrifugation experiments revealed that hNKCC2 sedimented predominantly as an approximately 320-kD complex, suggesting at least a dimeric configuration. The finding that dimerization occurs offers an explanation for the observations made by Meade et al. (20, 38) stating that the short or truncated isoforms of NKCC2 are able to affect negatively the longer isoforms by an unknown mechanism. Similar results have been reported for KCC1, for which several truncated mutants where shown to co-immunoprecipitate with the wild-type proteins (26). For other family members, such as NCC and KCC3, it has been stated that dimerization occurs for wild-type and mutant subunits, whereas several of the latter can also be detected at the plasma membrane (37,39).
The different isoforms of NKCC2 are expressed differentially along the distal tubule of the kidney, with the a isoform present in both the medullary and cortical segments of TAL, whereas the f and b isoforms are expressed predominantly in the medullary region and the macula densa, respectively (19). Together with our results, this strengthens the possibility that NKCC2 a isoforms could dimerize with either b or f in those cells where they are coexpressed. It is interesting that recent studies have shown differences in ion affinity for the a, b, and f NKCC2 isoforms, creating multiple possibilities for the physiologic regulation and modulation of NaCl transport in TAL (21,22,38).
To investigate the dimeric function more closely, we analyzed two hNKCC2 concatemers. The bumetanide-sensitive 22 Na ϩ uptake of the wild-type-wild-type concatemer was comparable to that of complexes formed upon injecting of monomeric hNKCC2 constructs. Next, we introduced the G319R mutation in one of the subunits of the concatemer. This mutation, identified in a study by Vargas et al. (40) , is normally processed and trafficked to the plasma membrane but functionally impaired when expressed in Xenopus oocytes (33). The wild-type-G319R concatemer heterologously expressed in oocytes was abundantly present at the plasma membrane. The bumetanide-sensitive 22 Na ϩ uptake of the wild-type-G319R was half that of the wild-type-wild-type concatemer. This could suggest that both hNKCC2 subunits in a dimer can function as separate transporters, although it is also possible that wild-type subunits in the wild-type-G391R mutant dimerize with adjacent wild-type subunits. Similar results have been reported for a lactose permease dimer, a transmembrane protein that shares several structural traits with the SLC12A family, in having a permease domain and 12 membrane-spanning ␣-helices. Sahin-Toth et al. (41) showed that introduction of an inactivating mutation in a concatemeric permease dimer reduced function by 50%, indicating that the subunits function as separate entities. Our results are in line with the fact that Bartter syndrome is a recessive disorder and thus no pathogenic phenotype would be present in a heterozygous situation. Thus, apparently enough transport capacity remains or wildtype-wild-type dimers are preferentially formed. It would, however, be interesting to study heterozygous carriers of Bartter mutations in more detail to investigate whether they present a phenotype under normal or challenged conditions, including a reduced BP or an increased susceptibility to diuretic-induced hypokalemia and hypercalciuria (3, 27) .
In conclusion, our data suggest that human NKCC2, when expressed in oocytes, forms at least homodimers of which the individual subunits can function independently. This might be applicable to all members of the SLC12A family, because also the close relatives NKCC1 and KCC1 form functional dimers. This knowledge substantiates our insight into the functional mechanism of the SLC12A co-transporter family and contributes to our understanding of NaCl reabsorption in TAL. 
